Carboxylic acid derivatives

The present invention pertains to a compound that has an excellent retinoic acid receptor-related orphan receptor [gamma] t inhibitory effect, or a pharmaceutically acceptable salt thereof. Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof. (In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GOTANDA, KENTOKU, ISOBE, TAKASHI, SASAKI, JUNKO, NOGUCHI, TETSUJI, YOSHINO, TOSHIHARU, RAMADASS, VENKATARAMANAN, GOTO, TAIJI, TORIHATA, MUNEFUMI, NAGAMOCHI, MASATOSHI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GOTANDA, KENTOKU
ISOBE, TAKASHI
SASAKI, JUNKO
NOGUCHI, TETSUJI
YOSHINO, TOSHIHARU
RAMADASS, VENKATARAMANAN
GOTO, TAIJI
TORIHATA, MUNEFUMI
NAGAMOCHI, MASATOSHI
description The present invention pertains to a compound that has an excellent retinoic acid receptor-related orphan receptor [gamma] t inhibitory effect, or a pharmaceutically acceptable salt thereof. Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof. (In the formula, R1 is a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a phenyl group. R2 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like. R3 is a hydrogen atom, a C2-C7 carboxyalkyl group, or a hydroxyl group. R4 is a halogen atom or a C1-C6 alkyl group. R5 is a hydrogen atom or a C1-C6 alkyl group. R6 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group. R7 is a hydrogen atom, a halogen atom, or the like. R8 is a hydroxyl group, a C1-C6 alkoxy group, a mono-C1-C6 alkylamino group, or the like. L is a single bond, a methylene group, or an oxygen atom. E is a phenylene group optionally substituted independently with one or two groups selected from halogen atoms, C1-C6 alkyl groups, and C1-C
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW201617314A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW201617314A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW201617314A3</originalsourceid><addsrcrecordid>eNrjZJB2TixKyq-ozMlMVkhMzkxRSEktyixLLMksSy3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxIeFGBoZmhubGhiaOxsSoAQCH7COv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Carboxylic acid derivatives</title><source>esp@cenet</source><creator>GOTANDA, KENTOKU ; ISOBE, TAKASHI ; SASAKI, JUNKO ; NOGUCHI, TETSUJI ; YOSHINO, TOSHIHARU ; RAMADASS, VENKATARAMANAN ; GOTO, TAIJI ; TORIHATA, MUNEFUMI ; NAGAMOCHI, MASATOSHI</creator><creatorcontrib>GOTANDA, KENTOKU ; ISOBE, TAKASHI ; SASAKI, JUNKO ; NOGUCHI, TETSUJI ; YOSHINO, TOSHIHARU ; RAMADASS, VENKATARAMANAN ; GOTO, TAIJI ; TORIHATA, MUNEFUMI ; NAGAMOCHI, MASATOSHI</creatorcontrib><description>The present invention pertains to a compound that has an excellent retinoic acid receptor-related orphan receptor [gamma] t inhibitory effect, or a pharmaceutically acceptable salt thereof. Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof. (In the formula, R1 is a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a phenyl group. R2 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like. R3 is a hydrogen atom, a C2-C7 carboxyalkyl group, or a hydroxyl group. R4 is a halogen atom or a C1-C6 alkyl group. R5 is a hydrogen atom or a C1-C6 alkyl group. R6 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group. R7 is a hydrogen atom, a halogen atom, or the like. R8 is a hydroxyl group, a C1-C6 alkoxy group, a mono-C1-C6 alkylamino group, or the like. L is a single bond, a methylene group, or an oxygen atom. E is a phenylene group optionally substituted independently with one or two groups selected from halogen atoms, C1-C6 alkyl groups, and C1-C</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160516&amp;DB=EPODOC&amp;CC=TW&amp;NR=201617314A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160516&amp;DB=EPODOC&amp;CC=TW&amp;NR=201617314A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOTANDA, KENTOKU</creatorcontrib><creatorcontrib>ISOBE, TAKASHI</creatorcontrib><creatorcontrib>SASAKI, JUNKO</creatorcontrib><creatorcontrib>NOGUCHI, TETSUJI</creatorcontrib><creatorcontrib>YOSHINO, TOSHIHARU</creatorcontrib><creatorcontrib>RAMADASS, VENKATARAMANAN</creatorcontrib><creatorcontrib>GOTO, TAIJI</creatorcontrib><creatorcontrib>TORIHATA, MUNEFUMI</creatorcontrib><creatorcontrib>NAGAMOCHI, MASATOSHI</creatorcontrib><title>Carboxylic acid derivatives</title><description>The present invention pertains to a compound that has an excellent retinoic acid receptor-related orphan receptor [gamma] t inhibitory effect, or a pharmaceutically acceptable salt thereof. Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof. (In the formula, R1 is a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a phenyl group. R2 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like. R3 is a hydrogen atom, a C2-C7 carboxyalkyl group, or a hydroxyl group. R4 is a halogen atom or a C1-C6 alkyl group. R5 is a hydrogen atom or a C1-C6 alkyl group. R6 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group. R7 is a hydrogen atom, a halogen atom, or the like. R8 is a hydroxyl group, a C1-C6 alkoxy group, a mono-C1-C6 alkylamino group, or the like. L is a single bond, a methylene group, or an oxygen atom. E is a phenylene group optionally substituted independently with one or two groups selected from halogen atoms, C1-C6 alkyl groups, and C1-C</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB2TixKyq-ozMlMVkhMzkxRSEktyixLLMksSy3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxIeFGBoZmhubGhiaOxsSoAQCH7COv</recordid><startdate>20160516</startdate><enddate>20160516</enddate><creator>GOTANDA, KENTOKU</creator><creator>ISOBE, TAKASHI</creator><creator>SASAKI, JUNKO</creator><creator>NOGUCHI, TETSUJI</creator><creator>YOSHINO, TOSHIHARU</creator><creator>RAMADASS, VENKATARAMANAN</creator><creator>GOTO, TAIJI</creator><creator>TORIHATA, MUNEFUMI</creator><creator>NAGAMOCHI, MASATOSHI</creator><scope>EVB</scope></search><sort><creationdate>20160516</creationdate><title>Carboxylic acid derivatives</title><author>GOTANDA, KENTOKU ; ISOBE, TAKASHI ; SASAKI, JUNKO ; NOGUCHI, TETSUJI ; YOSHINO, TOSHIHARU ; RAMADASS, VENKATARAMANAN ; GOTO, TAIJI ; TORIHATA, MUNEFUMI ; NAGAMOCHI, MASATOSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW201617314A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GOTANDA, KENTOKU</creatorcontrib><creatorcontrib>ISOBE, TAKASHI</creatorcontrib><creatorcontrib>SASAKI, JUNKO</creatorcontrib><creatorcontrib>NOGUCHI, TETSUJI</creatorcontrib><creatorcontrib>YOSHINO, TOSHIHARU</creatorcontrib><creatorcontrib>RAMADASS, VENKATARAMANAN</creatorcontrib><creatorcontrib>GOTO, TAIJI</creatorcontrib><creatorcontrib>TORIHATA, MUNEFUMI</creatorcontrib><creatorcontrib>NAGAMOCHI, MASATOSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOTANDA, KENTOKU</au><au>ISOBE, TAKASHI</au><au>SASAKI, JUNKO</au><au>NOGUCHI, TETSUJI</au><au>YOSHINO, TOSHIHARU</au><au>RAMADASS, VENKATARAMANAN</au><au>GOTO, TAIJI</au><au>TORIHATA, MUNEFUMI</au><au>NAGAMOCHI, MASATOSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Carboxylic acid derivatives</title><date>2016-05-16</date><risdate>2016</risdate><abstract>The present invention pertains to a compound that has an excellent retinoic acid receptor-related orphan receptor [gamma] t inhibitory effect, or a pharmaceutically acceptable salt thereof. Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof. (In the formula, R1 is a C1-C6 alkyl group, a C3-C6 cycloalkyl group, or a phenyl group. R2 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like. R3 is a hydrogen atom, a C2-C7 carboxyalkyl group, or a hydroxyl group. R4 is a halogen atom or a C1-C6 alkyl group. R5 is a hydrogen atom or a C1-C6 alkyl group. R6 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group. R7 is a hydrogen atom, a halogen atom, or the like. R8 is a hydroxyl group, a C1-C6 alkoxy group, a mono-C1-C6 alkylamino group, or the like. L is a single bond, a methylene group, or an oxygen atom. E is a phenylene group optionally substituted independently with one or two groups selected from halogen atoms, C1-C6 alkyl groups, and C1-C</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW201617314A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Carboxylic acid derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A24%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOTANDA,%20KENTOKU&rft.date=2016-05-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW201617314A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true